← Back to Clinical Trials
Recruiting NCT05734651

NCT05734651 PROMIS Evaluation Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05734651
Status Recruiting
Phase
Sponsor Bezirkskrankenhaus St. Johann in Tirol
Condition Hip Arthropathy
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2023-02-09
Primary Completion 2026-02-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
PROMIS Stem

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2023-02-09 with a primary completion date of 2026-02-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A total of 250 total hip arthroplasties (THA) are performed at the Bezirkskrankenhaus St. Johann. In a majority of those, implants from the company Falcon Medical (Austria) are used. Those implants are undergoing constant development and improvement. To guarantee their clinical performance, this clinical study is evaluating safety and efficacy of all implants produced by Falcon Medical. The purpose of this study is to evaluate the effcacy and safety of implants produced and distributed by Falcon Medical. All patients with primary THA and usage of a Falcon Medical implant are included. The outcome measures include intra-operative complications, early post-operative complications, revision for any cause and patient reported outcome (WOMAC questionnaire). All data is prospectively collected in a standardized fashion.

Eligibility Criteria

Inclusion Criteria: * Primary total hip arthroplasty with the PROMIS stem Exclusion Criteria: * n/a

Contact & Investigator

Central Contact

Moritz Wagner, MD

✉ moritz.wagner@khsj.at

📞 +4350536608167

Frequently Asked Questions

Who can join the NCT05734651 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Hip Arthropathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05734651 currently recruiting?

Yes, NCT05734651 is actively recruiting participants. Contact the research team at moritz.wagner@khsj.at for enrollment information.

Where is the NCT05734651 trial being conducted?

This trial is being conducted at Sankt Johann in Tirol, Austria.

Who is sponsoring the NCT05734651 clinical trial?

NCT05734651 is sponsored by Bezirkskrankenhaus St. Johann in Tirol. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology